Want to see COR full AI Analyst Report?
Operating Income by Segment
Measures each business segment’s profit after operating expenses, making it clear which units generate real bottom-line returns, where management is investing, and which segments may limit overall margin expansion or carry greater regulatory risk.U.S. Healthcare Solutions is the clear engine of profitability, delivering steady operating‑income momentum and carrying the company’s margin improvement despite near‑term revenue pressure from WAC cuts and account losses. International has regained traction but remains more volatile and a smaller contributor. The OneOncology acquisition and specialty logistics wins are boosting gross profit and lifting 'Other' profitability while adding interest and acquisition costs—explaining management’s decision to cut revenue guidance but raise operating‑income and EPS targets and resume meaningful buybacks, prioritizing margin leverage and cash returns.
Date | Other | U.S Healthcare Solutions | International Healthcare Solutions | Intersegment Eliminations |
|---|---|---|---|---|
Jun 30, 2026 | $108.74M | $966.18M | $165.85M | -$2.68M |
Mar 31, 2026 | $91.63M | $998.30M | $175.80M | -$2.38M |
Dec 31, 2025 | $91.42M | $831.33M | $142.16M | -$2.19M |
Sep 30, 2025 | $0.00 | $872.41M | $150.66M | $0.00 |
Jun 30, 2025 | $0.00 | $901.79M | $156.22M | $316.00K |
Mar 31, 2025 | $0.00 | $1.03B | $159.30M | -$187.00K |
Dec 31, 2024 | $0.00 | $767.34M | $182.09M | -$129.00K |
Sep 30, 2024 | $0.00 | $697.38M | $153.67M | $0.00 |
Jun 30, 2024 | $0.00 | $698.30M | $179.39M | $0.00 |
Mar 31, 2024 | $0.00 | $841.06M | $192.72M | $0.00 |